Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
- PMID: 10213686
- DOI: 10.1126/science.284.5414.641
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
Abstract
Primary effusion lymphoma (PEL) cells harbor Kaposi's sarcoma-associated herpesvirus (KSHV) episomes and express a KSHV-encoded latency-associated nuclear antigen (LANA). In PEL cells, LANA and KSHV DNA colocalized in dots in interphase nuclei and along mitotic chromosomes. In the absence of KSHV DNA, LANA was diffusely distributed in the nucleus or on mitotic chromosomes. In lymphoblasts, LANA was necessary and sufficient for the persistence of episomes containing a specific KSHV DNA fragment. Furthermore, LANA colocalized with the artificial KSHV DNA episomes in nuclei and along mitotic chromosomes. These results support a model in which LANA tethers KSHV DNA to chromosomes during mitosis to enable the efficient segregation of KSHV episomes to progeny cells.
Similar articles
-
Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.Virology. 2007 Jan 20;357(2):149-57. doi: 10.1016/j.virol.2006.07.052. Epub 2006 Sep 18. Virology. 2007. PMID: 16979209
-
Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.J Virol. 2019 Mar 5;93(6):e02158-18. doi: 10.1128/JVI.02158-18. Print 2019 Mar 15. J Virol. 2019. PMID: 30626680 Free PMC article.
-
Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.J Virol. 2013 Nov;87(22):12270-83. doi: 10.1128/JVI.01243-13. Epub 2013 Sep 4. J Virol. 2013. PMID: 24006437 Free PMC article.
-
The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.Future Microbiol. 2011 Dec;6(12):1399-413. doi: 10.2217/fmb.11.137. Future Microbiol. 2011. PMID: 22122438 Free PMC article. Review.
-
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.J Virol. 2017 Jun 26;91(14):e01083-16. doi: 10.1128/JVI.01083-16. Print 2017 Jul 15. J Virol. 2017. PMID: 28446671 Free PMC article. Review.
Cited by
-
Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins.PLoS Pathog. 2012;8(11):e1003048. doi: 10.1371/journal.ppat.1003048. Epub 2012 Nov 29. PLoS Pathog. 2012. PMID: 23209418 Free PMC article.
-
H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.J Virol. 2013 May;87(9):5255-69. doi: 10.1128/JVI.03575-12. Epub 2013 Feb 28. J Virol. 2013. PMID: 23449797 Free PMC article.
-
CRISPR Interference Efficiently Silences Latent and Lytic Viral Genes in Kaposi's Sarcoma-Associated Herpesvirus-Infected Cells.Viruses. 2021 Apr 28;13(5):783. doi: 10.3390/v13050783. Viruses. 2021. PMID: 33924938 Free PMC article.
-
KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22443-22451. doi: 10.1073/pnas.2004809117. Epub 2020 Aug 20. Proc Natl Acad Sci U S A. 2020. PMID: 32820070 Free PMC article.
-
DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.J Virol. 2001 Sep;75(17):7882-92. doi: 10.1128/jvi.75.17.7882-7892.2001. J Virol. 2001. PMID: 11483733 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
